Skip to main content
. 2019 Apr 30;17(2):155–169. doi: 10.9758/cpn.2019.17.2.155

Table 6.

Maintenance treatment across practice guidelines

Guidelines First-line treatment Next-step intervention Later intervention
KMAP-BP 201816) Preventing manic: MS+AAP, MS, AAP
Preventing depressive: MS+(AAP or LTG), MS, LTG, AAP, MS+AAP+LTG
Preventing manic: MS+LTG, 2 MSs, AAP+LTG
Preventing depressive: 2 MSs, MS+AAP+AD
Preventing manic: MS+AAP+LTG, LTG
Preventing depressive: AAP+AD, MS+AD
BAP 201617) Li If mania predominates; Val, OLZ, QTP, RIS LAI, CBZ, OXC
If depression predominates; LTG, QTP, lurasidone
Combination therapy, AD, CLZ, Maintenance ECT
CANMAT 201818) Li, QTP, Val, LTG, ASP, QTP+Li (or Val), ARP+Li (or Val), ARP, ARP OM OLZ, RIS LAI, RIS LAI (adj), CBZ, PAL, lurasidone+Li (or Val), ZIP+Li (or Val) ARP+LTG, OFC, CLZ (adj), gabapentine (adj)
CINP-BD-201719) Li, ARP, OLZ, PAL, QTP, RIS, RIS LAI Add FX or Li, Li+CBZ, QTP+Li (or Val), MS+OLZ (or ARP) Add RIS LAI or CBZ or LTG or N-acetylcysteine
NICE 201423) Li Val, OLZ, QTP
WFSBP 201326) ARP (mania and any episode), LTG (depression and any episode), Li (any episode), QTP (any episode) OLZ (mania and any episode), RIS (mania and any episode) AD (depression), PAL (mania and any episode), Val (depression), adjunctive ZIP (mania and any episode)

KMAP-BP, Korean Medication Algorithms for Bipolar Disorder; BAP, The British Association for Psychopharmacology Guidelines for Treatment for Bipolar Disorder; CANMAT 2018, Canadian Network for Mood and Anxiety Treatments; CINP-BD, International College of Neuro- Psychopharmacology Treatment Guidelines for Bipolar Disorder; NICE, National Institute for Health and Clinical Excellence Treatment for Bipolar Disorder; WFSBP, World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Bipolar Disorder: Maintenance treatment; MS, mood stabilizer; AAP, atypical antipsychotic; LTG, lamotrigine; AD, antidepressant; Li, lithium; Val, various kinds of valproic acid; OLZ, olanzapine; QTP, quetiapine; RIS LAI, risperidone long-acting injectable; CBZ, carbamazepine; OXC, oxcarbazepine; AD, antidepressant; CLZ, clozapine; ECT, electroconvulsive therapy; ASA, asenapine; ARP, aripiprazole; ARP OM, aripiprazole once monthly; adj, adjunctive; PAL, paliperidone; ZIP, ziprasidone; OFC, olanzapine-fluoxetine complex; FX, fluoxetine.